Colorectal Cancer Article Analysis

922 Words 4 Pages
This article discusses how non-steroidal anti-inflammatory drugs, such as ibuprofen, may help protect against colorectal cancer. Yet, how much had to be taken, and for how long, to achieve those benefits is still being currently studied. Through some research, I found that African Americans are more likely to be diagnosed with colorectal cancer. There might be a correlation with cardiovascular disease and colorectal cancer since they are both high in African Americans. Therefore, the increase use of aspirin to self-medicate against cardiovascular disease may lower colorectal cancer. I wonder who is more likely to take daily aspirins among all the ethnicities. I would think that ethnicities that normally do not go to the doctor, such as blacks, …show more content…
Their goals include increase data collection, reduce health disparities, and increase healthcare workers in vulnerable populations, decrease language barriers. They hope to achieve this goal by higher burden of disease, get a lower quality of care, and find barriers to access. I am worried about the effectiveness of their plan. After looking through the internet, I could find an article with a detailed plan to support this claim. All I got was that they plan to collect more data through survey so stakeholders can figure out a plan (www.cms.gov). More data is helpful in identify who is at risk, yet does not give a way to help them until analysis of the data is complete, unlike what the article implies (which is a plan to help those in need is already created). Even then, there may not be a true plan in place. This tells me that that even do not know how to achieve their goals and now I am very disappointed with the …show more content…
This was shocking to me because I was unaware that there was a preventative drug for HIV. I feel incorporating information of these drugs during discussion of safe sex could benefit the course as a whole. These medications are available to patients in industrialized countries and those in the developing world. In addition, this article also addressed that about a decade ago, disturbing $15,000 medications (which it would have cost) to individuals in developing countries looked impossible. Now, the number of people getting treatment in developing has been rising by about a million every year. However, I question the ability (funds to ship and deliver) of distribute these to the individuals in need in these third-world country. Also, I know the prices can only get so low because pharmaceutical companies still want to make a profit, so they don’t want to be totally free. Therefore, what about those who have to have sex to make money in developing companies (who are at high risk). They barely have money feed themselves, let alone pay for these

Related Documents